BIOPHYTIS

Biophytis $ALBPS Receives Approval from the Belgian Regulatory Agency to Proceed with the MYODA Program for Clinical Development of Sarconeos (BIO101) in Patients with DMD https://biophytis.com/wp-content/uploads/2020/03/Biophytis-MYODA-Belgium-authorisation-EN-PR.pdf